Table 2.
Ref.
|
Subclass
|
Marker
|
Main methods
|
Yamashita et al[158] | Type A-D | EpCAM, AFP | cDNA microarray, IHC |
Lee et al[157,159] | Cluster A and B, and 3 distinct phenotypes | Sets of survival genes, AFP | Integrated cDNA microarray in human specimens and animal models |
Boyault et al[160] | Groups G1-G6 | Tumor heterozygosity, gene mutations, methylation, and HBV DNA | cDNA microarray, IHC, qRT-PCR |
Hoshida et al[161] | Subclasses S1-S3 | Cellular differentiation, serum AFP, signaling pathways | Meta-analysis of gene expression profiles datasets, IHC |
Sia et al[163] | Immune classes active and adaptive | Immune response genes | cDNA microarray, IHC, TCGA analysis |
Zhang et al[164] | Immunophenotypic subtypes 1-3 | Immune response genes and antitumoral immunity | Whole-exome and RNA sequencing, mass spectrometry-based proteomics and metabolomics, CyTOF, single-cell analysis |
HBV: Hepatitis B virus; IHC: Immunohistochemistry; TCGA: The Cancer Genome Atlas; AFP: Alpha-fetoprotein; qRT-PCR: Quantitative real-time polymerase chain reaction.